OSI-7904L

DRUG4 trials

Sponsors

OSI Pharmaceuticals, European Organisation for Research and Treatment of Cancer - EORTC

Conditions

Advanced Solid TumorsColorectal CancerGastric AdenocarcinomaGastroesophageal AdenocarcinomaLocally Advanced or Metastatic Adenoca of the Biliary Tract

Phase 1

OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer

CompletedNCT00081237

European Organisation for Research and Treatment of Cancer - EORTCColorectal Cancer

Start: 2004-02-29Updated: 2013-06-12

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

CompletedNCT00116896

OSI PharmaceuticalsAdvanced Solid Tumors

Start: 2003-06-30End: 2004-12-31Target: 25Updated: 2009-01-21

Phase 2

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

CompletedNCT00073502

OSI PharmaceuticalsGastric Adenocarcinoma, Gastroesophageal Adenocarcinoma

Start: 2003-10-31End: 2003-10-31Target: 43Updated: 2006-02-22

A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

CompletedNCT00088270

OSI PharmaceuticalsLocally Advanced or Metastatic Adenoca of the Biliary Tract

Start: 2004-08-31End: 2005-08-31Target: 58Updated: 2006-02-22